Muscle & Brawn 2.0 is live! New Tools, Voice Reader, Compound Index, Features and more on the way. Want to explore what’s new → Click Here
Independent & reader-supported — every article medically reviewed

Cycle support / SERMs

12 In the index

Toremifene TOREM

An FDA-approved breast cancer medication, also studied off-label to help with male fertility and hormone levels in a way similar to related fertility drugs. Its cancer use is strongly proven; the off-label fertility use is supported by smaller studies using the same hormone-blocking mechanism.

Also known as Fareston, Acapodene, Farestone, Toremifeno, Toremifenum, Chlortamoxifen, Toremiphene, GTx-006

Effects Hormonal
Routes Oral
Legal status Prescription drug
WADA Banned at all times

3D Molecular Structure of C26H28ClNO

Drag to rotate · scroll to zoom

  • Carbon
  • Hydrogen
  • Chlorine
  • Nitrogen
  • Oxygen

Chemistry

Formula
C26H28ClNO
Molar mass
406.0
CAS
89778-26-7
PubChem CID
3005573
IUPAC name
2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine
InChIKey
XFCLJVABOIYOMF-QPLCGJKRSA-N

Reported dosing

User-reported

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 60 mg/day
Reported range 20-240 mg/day depending on indication
Route Oral
Frequency Once daily
Duration Chronic (oncology, as prescribed) or off-label short-term use (fertility support)

FDA-approved SERM (Fareston) for breast cancer; also studied off-label for male fertility/hormone support using a similar mechanism to related fertility drugs.

Where this comes from FDA prescribing information; off-label user-reported dosing

There is no approved human dosing for this compound. The figures above are what users and vendors report, not what has been established as safe or effective. Treat them as a record of what is done, not as guidance.